Herpesviruses acquire a primary envelope by budding of capsids at the inner leaflet of the nuclear membrane. They then traverse into the cytoplasm after fusion of the primary envelope with the outer leaflet of the nuclear membrane. In the alphaherpesvirus pseudorabies virus (PrV), the latter process is impaired when the US3 protein is absent. Acquisition of final tegument and envelope occurs in the cytoplasm. Besides the capsid components, only the UL31 and UL34 gene products of PrV have unequivocally been shown to be part of primary enveloped virions, whereas they lack several tegument proteins present in mature virions (reviewed by T. C. Mettenleiter, J. Virol. 76:1537-1547, 2002) . Using immunoelectron microscopy, we show that the US3 protein is present in primary enveloped as well as in mature virions. It is also detectable in intracytoplasmic inclusions produced in the absence of other viral tegument components or envelope-associated glycoproteins. In particular, inclusions formed in the absence of the inner tegument protein UL37 contained the US3 protein. Thus, the US3 protein is a tegument component of both forms of enveloped alphaherpes virions. We hypothesize that US3 protein in primary virions modulates deenvelopment at the outer leaflet of the nuclear membrane and is either lost from primary virions during nuclear egress and subsequently reacquired early during tegumentation or is retained during transit of the nucleocapsid through the nuclear membrane.
Herpesvirus morphogenesis is a complex process. The viral DNA genome is replicated and packaged into preformed icosahedral capsids in the nucleus of the host cell. Nucleocapsids are then translocated through the nuclear membrane into the cytoplasm by an envelopment-deenvelopment process. To this end, intranuclear capsids obtain a first (primary) envelope by budding at the inner leaflet of the nuclear membrane, in this process also acquiring a primary tegument, resulting in the presence of primary enveloped herpes virions between the two leaflets of the nuclear membrane. The primary envelope then fuses with the outer leaflet of the nuclear membrane, and nucleocapsids are released into the cytoplasm. They then obtain their final set of tegument proteins, as well as their final envelope with mature viral glycoproteins, by budding into trans-Golgi vesicles. Release of free infectious virions is subsequently achieved by fusion of vesicle and plasma membrane (reviewed in reference 34) .
For the formation of primary virions, the UL31 and UL34 proteins of pseudorabies virus (PrV), herpes simplex virus type 1 (HSV-1), and murine cytomegalovirus have been shown to play important roles (6, 13, 23, 35, 50) . In their absence, primary envelopment at the inner leaflet of the nuclear membrane is blocked, and nucleocapsids accumulate in the nucleus. Since UL34 is predicted to be a type II transmembrane protein, it was proposed that it may represent a primary envelope protein and that the UL31 gene product may be part of the primary tegument. Both proteins physically interact which is in accordance with these assumptions (13, 35, 48) .
Analysis of lipid composition first demonstrated that the envelope of mature HSV-1 particles is distinct from the nuclear membrane, indicating that the mature viral envelope may not be derived from the nuclear membrane (55) . Subsequent electron microscopic data substantiated that primary enveloped and mature virions are also morphologically distinct. Whereas mature herpes virions are characterized by a fuzzy electron-dense tegument and an envelope with clearly visible projections (spikes), primary enveloped virions lack the typical spikes and their tegument is tightly juxtaposed to the envelope in a sharp bordered rim (17, 18) . Since perinuclear virions have thus far not been purified to any extent to allow unequivocal analysis of their protein content, immunoelectron microscopy has been used to study their composition. These data clearly showed that the UL34 and UL31 proteins are constituents of primary virions (13, 23, 49) . Since they also contain nucleocapsids, it is reasonable to assume that capsid proteins (the products of the UL18, UL19, UL35, and UL38 genes [52] ) and capsid-associated proteins such as the UL6 portal protein (36) may also be part of these virus particles. Whether other envelope or tegument proteins are also present in primary virions is unclear.
In the subsequent fusion of primary envelope and outer leaflet of the nuclear membrane the US3 protein plays an important role. In its absence, primary enveloped virions accumulate in the perinuclear space, which is due to an apparent defect in deenvelopment (24, 49) . Consequently, it had to be assumed that the US3 protein may be associated with primary virions. The HSV-1 and PrV US3 proteins are protein kinases (43, 47, 59) , homologs of which are present in the alphaherpesviruses but not in the other herpesvirus subfamilies (1, 7, 32) . In contrast, the UL13 gene products, which also represent protein kinases (10, 30, 37, 38, 51, 53) , are conserved in all herpesvirus subfamilies. Neither the UL13 nor the US3 homologs are required for viral replication (10, 20, 24, 46, 47) . Interestingly, although HSV-1 US3 has been proposed to phosphorylate the UL34 protein (44, 45) , it has been shown that phosphorylation of the PrV UL34 protein was not altered in the absence of the US3 gene (24) . Thus, lack of phosphorylation of the UL34 protein due to absence of US3 is not the reason for the observed de-envelopment defect. We hypothesized that US3 may play an important structural role in primary virions which is relevant for the fusion process.
MATERIALS AND METHODS

Viruses and cells.
PrV mutants were derived from the laboratory strain Kaplan (PrV-Ka [19] ). Viruses were grown in rabbit kidney (RK13) or porcine kidney (PSEK) cells in minimal essential medium supplemented with 10 or 5% fetal calf serum, respectively. Isolation and characterization of PrV-⌬US3 (24), PrV-⌬UL37 (25), PrV-⌬UL47 (27) , PrV-⌬UL48 (14), PrV-⌬UL3.5 (16) , PrV-⌬UL11 (28) , and PrV-gEIM Ϫ (4) have been described. PrV strain Becker (PrV-Be [3] ) was kindly provided by L. W. Enquist, Princeton University. An aliquot of the original isolate of strain Bartha K61 (PrV-Ba [2] ) was generously provided by the late A. Bartha, Budapest, Hungary.
Western blot analysis. Virus purification and preparation of infected cell lysates were done as described recently (28) . Samples of infected cell lysates and purified virions were separated by sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis (29) and electrotransferred onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany [54] ). Blots were blocked with 6% skim milk in phosphate-buffered saline and incubated with monospecific sera against the UL11 (1:10,000 [28] ), UL31 (1:100,000 [13] ), UL34 (1:100,000 [23] ), UL37 (1:100,000 [25] ), UL46 (1:100,000 [27] ), UL47 (1:100,000 [27] ), UL48 (1:100,000 [14] ), UL49 (1:100,000 [5] ), glycoprotein H (gH; 1:50,000 [22] ), gD (1:10,000 [21] ), gI (1:10,000 [4] ), and gM (1:50,000 [28] ) proteins or with monoclonal antibodies against gB (b43-b5 [40] ), gC (B16-c8 [24] ), gE (A9-b15 [21] ), and gK (11) . Bound antibody was detected with peroxidase-conjugated secondary antibodies (Dianova, Hamburg, Germany) and visualized by chemiluminescence (Super Signal; Pierce) recorded on X-ray films.
Immunoelectron microscopy. Immunoelectron microscopy using specific antibodies and 10-nm gold-tagged secondary anti-rabbit antibodies (GAR10; British Biocell International) was performed as described recently (28) . Ultrathin sections were counterstained and analyzed with an electron microscope (Tecnai 12; Philips, Eindhoven, The Netherlands). In addition to the antisera mentioned above, a UL36 specific polyclonal serum was used (26) .
RESULTS
US3 protein is part of primary virions.
To analyze the association of US3 protein with primary virions, electron microscopic examinations were performed. RK13 cells infected with PrV-Ka were fixed 14 h after infection and analyzed by conventional and immunoelectron microscopy. Monospecific antisera against the UL31, UL34, US3, UL36, UL37, UL46, UL47, UL48, UL49, and US3 proteins were used. All stages of virus maturation could be identified, including the presence of perinuclear enveloped virions ( Fig. 1A ). As expected, these virions labeled with the anti-UL31 and anti-UL34 antisera ( Fig. 1B and C) but failed to show reactivity with antisera directed against the UL36, UL37, UL46, UL47, UL48, and UL49 tegument proteins ( Fig. 1D to I). In contrast, extracellular virions ( Fig. 2A ) labeled with the anti-tegument protein antisera ( Fig. 2D to I) but failed to react with the anti-UL31 and anti-UL34 sera ( Fig. 2B and C) . Surprisingly, both perinuclear primary enveloped ( Fig. 1J ) and extracellular mature virions ( Fig. 2J) were labeled by the anti-US3 antiserum. Thus, US3 apparently is part of both primary and mature virions. In contrast, the UL31 and UL34 proteins are only present in primary virions, and the major tegument components of ma-ture virus particles UL36, UL37, UL46, UL47, UL48, and UL49 were not detectable in primary virions.
Since the anti-US3 antiserum was the only serum that reacted with primary enveloped and mature virus particles, we verified the specificity of the antiserum by using cells infected with a US3 deletion mutant of PrV (24) . As previously observed, in the absence of the US3 protein primary envelopment occurred but deenvelopment was impaired, resulting in the accumulation of primary virions in the perinuclear space in large invaginations of the inner leaflet of the nuclear membrane (24, 49, 57) (Fig. 3A) . These primary virions did not label with the US3 antiserum ( Fig. 3B) , whereas the anti-UL31 ( Fig. 3C ) and anti-UL34 ( Fig. 3D ) antisera detected their respective antigens in PrV-⌬US3 primary enveloped virions.
Correlating with its incorporation into primary enveloped virions, US3 protein was also detectable at the nuclear membrane ( Fig. 4A ) in PrV-Ka-infected cells, although it appeared less prominent than the UL31 (Fig. 4B ) or UL34 (Fig. 4C ) proteins. To summarize, the PrV US3 protein is present in infected cells at the nuclear membrane and is incorporated into perinuclear virions during primary envelopment.
US3 protein is present at intracytoplasmic nucleocapsids that accumulate in the absence of tegument or envelope glycoproteins. To analyze whether US3 is retained at the nucleocapsid during nuclear egress or whether it is reacquired in the cytosol, mutant viruses with defects at different stages of the intracytoplasmic virion maturation pathway were analyzed ( Fig. 5 ). US3 protein was present in inclusions formed in the absence of the UL47 tegument protein ( Fig. 5C and D) (27) or the UL11 tegument protein ( Fig. 5I and J) (28) or in the simultaneous absence of envelope glycoproteins E, I, and M ( Fig. 5K and L) (4) . The anti-US3 serum also labeled intracytosolic capsids which accumulate in the absence of the UL48 (Fig. 5E and F) (14) or UL3.5 ( Fig. 5G and H) (16) proteins. It has previously been shown that absence of these respective viral component(s) impairs virion formation prior to secondary envelopment (4, 5, 14, 16, 27, 28) . In the absence of the UL37 protein, which presumably forms one of the inner layers of tegument around the nucleocapsid by physically interacting with capsid-bound UL36 protein (26, 60) , nucleocapsids aggregate in the cytoplasm in an ordered arrangement ( Fig. 5A ) (25) . Since these inclusions, besides the UL36 protein, do not contain major components of the mature tegument such as the UL49 protein (25) , they most likely contain nucleocapsids blocked early in tegumentation. However, these nucleocapsids also labeled with the anti-US3 antiserum (Fig. 5B) , indicating that the US3 protein is either retained during nuclear egress or reacquired very early during tegumentation.
Absence of US3 protein does not alter composition of mature virions. During formation of mature virions intricate protein-protein interactions among tegument components and between tegument and envelope constituents occur (reviewed in reference 34). To analyze whether the absence of the US3 tegument component alters incorporation of other tegument or envelope proteins, purified PrV-⌬US3 virions were analyzed by Western blotting with monospecific antisera or monoclonal antibodies. As shown in Fig. 6 , in comparison to purified wildtype PrV-Ka virions (Fig. 6, lanes 1) the absence of the US3 protein in PrV-⌬US3 (Fig. 6 , lanes 2) did not result in an alteration in the incorporation of other tegument proteins such 6B ) nor of the envelope glycoproteins gB, gC, gD, gE, gI, gH, gK, or gM (Fig. 6C) . Thus, at least these tegument and envelope proteins are incorporated into mature virions independent of the US3 protein.
US3 protein is packaged into mature PrV-Bartha virions. It has previously been described that the attenuated live vaccine strain PrV-Bartha does not package US3 protein into mature virions (31) . Among other mutations (reviewed in reference 33), PrV-Bartha contains a deletion in the Us genome region encompassing the gE, gI, and US9 genes (42) . Since this could indicate a requirement for these proteins for virion incorporation of US3, we analyzed virions of PrV-Bartha (PrV-Ba) by using stock virus from the original Hungarian isolate. Virus was grown in RK13 cells and purified by centrifugation through a discontinuous 30 to 50% sucrose gradient as described previously (27) . For comparison, wild-type strains PrV-Ka and PrV-Be were included. As shown in Fig. 7 , PrV-Ka, PrV-Be, and PrV-Ba virions all contained similar amounts of tegument protein UL37, as well as gH, whereas gE, as expected, was absent from PrV-Ba. Surprisingly, PrV-Ba also contained unaltered amounts of US3. Therefore, the packag-ing of US3 is apparently not dependent on the presence of either gE or gI. In contrast to earlier descriptions (31), we also found that PrV-Ba virions contained the major tegument protein UL49.
DISCUSSION
Our data provide the first exhaustive analysis of the composition of primary enveloped perinuclear virions by immunolabeling. Unfortunately, this is currently the only method available for analysis of these intermediates in herpesvirus maturation, since no reliable protocol for purification of perinuclear virions has yet been found. In our studies (see Fig. 1 ), perinuclear virions labeled with the UL31-and UL34-specific antisera but not with antisera directed against the UL36, UL37, UL46, UL47, UL48, or UL49 tegument proteins of mature virions. In contrast, mature virions (Fig. 2) were not recognized by the UL31 and UL34 specific antisera but readily labeled with antisera against the other tegument proteins. Thus, our data fully support the envelopment-deenvelopmentreenvelopment model of herpesvirus morphogenesis since they show that the two forms of nucleocapsid-containing enveloped herpesvirus particles, i.e., primary and mature virions, have a different protein composition. However, we cannot completely rule out that amounts of tegument proteins that are below the detection limit of our antisera may be present on primary virions, although this appears to be unlikely. Also, even posttranslationally altered forms of the proteins should have been detectable by our potent polyclonal monospecific antisera.
The only protein that we detected as part of the tegument of primary and mature PrV virions was US3. This has recently also been proposed for the homologous HSV-1 protein (49) . The PrV US3 gene is transcribed into two mRNAs which are translated into two C-terminally identical US3 proteins (56, 58) . Whereas both translation products of 41 and 53 kDa are present in infected cells, only the smaller protein of 41 kDa was detected in mature virus particles (31) . Since our antiserum is directed against a part of the US3 protein common to both forms, it detects both US3 translation products. Therefore, we cannot differentiate at the moment whether different forms of the US3 protein may associate with virions during primary and secondary envelopment.
In the absence of the UL37 tegument protein, which interacts with the capsid-associated UL36 tegument protein (26), tegumentation is inhibited at an early step, resulting in the accumulation of intracytoplasmic clusters of capsids in an ordered arrangement (25) . Our immunoelectron microscopic analyses proved that these clusters contained the US3 protein. Thus, the data indicate that the US3 protein is either retained during nuclear egress or reacquired early during tegumentation in the cytosol.
Recent data indicated that expression of gE and/or gI may be important for virion localization of US3 since the attenuated PrV vaccine strain Bartha (2), was found not to package the US3 or UL49 proteins (31) . PrV-Bartha, among other defects, lacks the genes encoding gE and gI (reviewed in reference 33), and carries point mutations within the gM gene resulting in the elimination of an N-glycosylation site (12) . Moreover, the UL49 tegument protein had previously been shown to interact with the cytoplasmic tail of gE and gM (15) .
Since the gE and gI genes are absent from the PrV-Ba genome and gM is modified, these defects could account for the observed lack of incorporation of UL49. However, our preparations of gradient-purified PrV-Ba virions obtained from an original seeding stock of this virus clearly contained both UL49 and US3 proteins. Whether this difference is due to a differ- The US3 protein, in addition to its role as a virion structural component, also exhibits protein kinase activity (47, 59) . Although the UL34 protein has been described as one of the substrates for modification by US3 (44, 45) and the presence or absence of US3 has been shown to influence intracellular localization of the UL34 protein (24) , no difference in the phosphorylation state of the PrV UL34 protein has been detected (24) irrespective of the presence or absence of US3. Thus, the protein kinase activity of US3 may not be relevant for the processes analyzed here. It is conceivable that during tegumentation in primary and secondary envelopment, the US3 protein primarily plays a structural role.
The two noncapsid proteins that have thus far been shown to play an important role in primary envelopment, the UL31 and UL34 gene products, are conserved throughout the herpesviruses (1, 7, 32) , indicating that they execute a function which is fundamental to herpesvirus replication. We hypothesize that these two proteins may be part of an ancient herpesvirus fusion machinery which is simple (perhaps consisting of only these two proteins) and efficient (it is difficult to detect virions in the process of deenvelopment by electron microscopy). The nonconserved US3 protein may have evolved to play a modulatory role in this process since in its absence deenvelopment is inhibited but not completely blocked, and the resulting reduction of extracellular virus titers is only ϳ10-fold. In contrast, absence of the UL31 or UL34 proteins reduces virus titers by 100-to 1,000-fold.
It is currently unclear whether there is redundancy in the functions US3 executes. The large subunit of the ribonucleotide reductase, expressed from homologs of the HSV UL39 gene, can function as a protein kinase (8, 39) . Morever, herpesviruses from all subfamilies encode a protein kinase, homologous to the UL13 protein of HSV-1, whose exact function is not yet clear, although it has been demonstrated to phosphorylate several substrates, including gE/gI (38) (9), and it modulates UL41 function (41) . However, neither gE nor UL41 nor UL49 are conserved in the herpesvirus family, which results in a seeming paradox: a conserved viral protein has as major substrates nonconserved viral proteins. Thus, it may be conceivable that UL13 compensates in part for loss of US3, perhaps even in nuclear egress. It has indeed been shown that a PrV double mutant lacking US3 and UL13 exhibits a severe growth defect (10) . It will be interesting to analyze whether the UL13 protein is also present in primary enveloped and mature virions and whether the concomitant absence of both kinases results in a more drastic effect on nuclear egress. The observed presence of US3 protein in primary enveloped and mature virions correlates with its intracellular distribution during virus infection (24, 31) . During infection it is detectable in both, the nucleus and the cytoplasm. However, so are other PrV tegument proteins such as UL47 (27) or UL48 (14) , but these are apparently not incorporated into primary virions. Therefore, either a specific sorting mechanism exists which limits access to nascent primary virions for the "correct" constituents, or the intranuclear distribution of those proteins which are part of the mature virion but do not become part of the primary virus particle is different from that of US3 to prevent access to the nascent virus. It is also conceivable that differences in the temporal regulation of gene expression, e.g., early versus late kinetics, may influence localization of proteins in the virus particle.
In summary, our studies identify the US3 protein, a nonconserved herpesvirus protein, as the first tegument component described thus far that is part of the primary enveloped and of the mature virion. Whether the impairment in deenvelopment that is observed in the absence of the US3 protein reflects an important structural role for this protein in primary enveloped virions or whether it is due to effects of its kinase function remains to be analyzed.
